Perspectives
Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis B virus infection
Abstract
Hepatitis B virus (HBV) infection is one of the major risk factors in the development of hepatocullular carcinoma (HCC) worldwide.